Director dealings explained: starting points

Director dealings are share transactions carried out by company directors or persons discharging managerial responsibilities (PDMRs) and persons closely associated with them. Under the UK Market Abuse Regulation (UK MAR), such transactions must be disclosed to the market within three Business days of the trade. These filings are published via the London Stock Exchange's Regulatory News Service (RNS) and republished by data providers including Sharecast, Hargreaves Lansdown and Investegate.

For private investors, director dealings have long been one of several signals worth tracking. Academic and broker research suggests that aggregated director buying can, over time, modestly outperform broader benchmarks, although results vary widely by company and by year. Director purchases are often interpreted as a sign of management confidence, while director sales can have many explanations, including tax planning, Diversification, the funding of share option exercises, or simple personal Liquidity needs. None of these transactions, on their own, indicates wrongdoing or future performance, but investors may still watch them closely as one input among many.

CVS Group (CVSG): a small insider buy in a regulated sector

CVS Group's group general counsel Scott Morrison purchased 987 shares at 1,269.68p, for £12,531.75, as disclosed in the 28 May 2026 Hargreaves Lansdown / Sharecast round-up. The trade is small in absolute terms but visible because CVS Group is a FTSE 250 stock that has been working through a more challenging share price phase amid the CMA market investigation into the Supply of veterinary services for household pets.

For investors, the buy is an example of a senior insider in a regulated sector committing personal Capital. Director purchases are often monitored by the market, but the dealing may draw attention without necessarily indicating future share price performance.

Naked Wines (WINE): turnaround insider buying

Naked Wines was listed twice in the day's top director buys, with director Jack Pailing buying 26,500 shares at 75.00p (£19,875.00) and 26,250 shares at 75.00p (£19,687.50). The combined £39,562.50 of director-linked buying takes place at a substantially reset share price, well below the company's Pandemic-era highs.

Bulls interpret the buys as insider conviction in the ongoing turnaround; bears note that the AIM-listed online wine retailer is still in transition. The transaction does not necessarily indicate future share price performance.

Star Energy (STAR): option-related director sales

Star Energy's combined director sales totalled 350,016 shares at 16.00p, for £56,002.56. The CEO Ross Glover sold 289,541 shares (£46,326.56) and CFO Frances Ward sold 60,475 shares (£9,676.00). The company has stated that the sales were carried out to satisfy tax and national insurance liabilities arising from the exercise of share Options.

This is a routine and well-understood reason for director selling at UK-listed companies, and is generally read less negatively than purely discretionary disposals. Director selling can happen for many personal or financial reasons.

Why investors monitor director buys

Private investors often pay attention to director purchases because the people transacting have a near-front-row seat to operational performance. They know the order book, the pipeline, the customer base and the trading environment. A director who chooses to put personal capital into the same shares they are paid to manage is, at minimum, signalling that they do not expect a near-term collapse in fundamentals.

However, this signal can be noisy. Directors are sometimes required to maintain a minimum shareholding, and some buys are small relative to a director's overall Wealth. A purchase made by a newly appointed director, for example, can be more about complying with internal shareholding guidelines than a directional view on the share price. Investors may watch director purchases, but they are typically most useful when assessed alongside fundamentals, valuation, guidance and any recent trading updates.

Why investors monitor director sells

Director selling is the more emotionally charged side of director dealings, but it is equally important to read it carefully. Many disposals are routine: they can fund tax bills associated with the exercise of share options or performance share awards, satisfy obligations under a long-term incentive plan, or simply represent diversification by an executive whose net worth is concentrated in one stock.

Market Participants typically focus on the context: the size of the disposal relative to the director's holdings, whether it follows a strong run in the share price, and whether the timing is consistent with recent trading updates or upcoming results. Director selling can happen for many personal or financial reasons, and the dealing may draw attention, but it should be assessed alongside fundamentals, not treated as a stand-alone trading signal.

Bull case across the transactions

Bulls argue that director buys at CVS Group and Naked Wines reflect insider conviction in the longer-term direction of each business, even where the share price has been under pressure. They argue that the Star Energy sales, being explicitly tied to option-related tax, do not change the underlying STAR Investment case.

From this view, the three transactions together highlight how UK insider behaviour can be more nuanced than headline figures suggest. Director purchases are often monitored by the market, while director sells for tax purposes are sometimes read more neutrally.

Bear case across the transactions

Bears note that none of the director buys is particularly large in absolute terms, and that the Star Energy sales, even if tax-related, add to supply at a delicate price level in an AIM stock. They argue that the underlying business cases — CMA exposure at CVS Group, turnaround risk at Naked Wines, and the structural challenges of UK onshore oil and gas at Star Energy — remain unchanged by any single director transaction.

Key risks across the three names

CVS Group's primary risk is CMA-related regulatory exposure, alongside operational and currency risks. Naked Wines' key risks include subscriber durability, Working Capital intensity, FX exposure and AIM liquidity. Star Energy's risks include UK onshore decline rates, planning and regulatory considerations, geothermal development timelines, Commodity price exposure and AIM liquidity.

Investors building views on any of these names should consider the relevant fundamentals before placing too much weight on a single director dealing.

How to use director dealings in practice

Director dealings work best as one input within a broader process. Investors who use them effectively typically look at: the seniority of the buyer or seller, the absolute and proportional size of the transaction, the stated reason where available, the recent share price context, the company's most recent trading updates, and any broader sector or regulatory dynamics.

Director dealings are not, on their own, a trading signal. The dealing may draw attention, but it should be assessed alongside fundamentals.

Balanced conclusion

Across CVS Group, Naked Wines and Star Energy, the recent director dealings illustrate the full spectrum of insider activity in the UK market. From a modest senior insider buy at a FTSE 250 vet group, to turnaround-stock director buying at an AIM retailer, to option-related sales at a small-cap energy company, each transaction has its own context and meaning.

None of these transactions, on their own, indicates future share price performance. But each one adds to the body of disclosed information that UK investors can use, alongside fundamentals, to build informed views on the respective companies.

UK Market Abuse Regulation and PDMR disclosures explained

Under the UK Market Abuse Regulation (UK MAR), persons discharging managerial responsibilities (PDMRs) at issuers admitted to a UK regulated market or multilateral trading Facility must notify both the issuer and the Financial Conduct Authority (FCA) of every transaction conducted on their own account in the shares or Debt instruments of that issuer, or in related financial instruments. Notification must take place within three business days of the transaction. The issuer is, in turn, required to make the information public promptly via a Regulatory Information Service (RIS) such as the London Stock Exchange's RNS service. The same rules apply to persons closely associated with PDMRs, which can include spouses, dependent children, and certain associated legal entities.

The rationale behind UK MAR is to support market integrity. By requiring rapid, public disclosure of insider transactions, the regulation aims to ensure that investors have access to the same information about board-level engagement with their company's shares. There is also a 'closed period' regime, under which PDMRs are typically prohibited from dealing for a 30-day window before the publication of interim or annual financial reports, unless specific exemptions apply. These rules sit alongside broader UK MAR provisions on insider lists, market soundings and the prevention of insider dealing and market manipulation. For investors, the practical takeaway is that director dealings disclosures are not informal updates: they are mandatory, time-bound notifications made under a regulatory framework that takes market abuse seriously.

Director dealings versus other signals UK investors track

Director dealings are best understood as one input within a broader signal set. Other commonly tracked inputs for UK shares include trading updates (which provide direct commentary from management on operational and financial performance), broker consensus forecasts (which aggregate analyst expectations on Revenue, profit and dividends), short interest data (which indicates the scale of bearish positioning), institutional shareholding changes filed via TR-1 notifications, and Macroeconomic Indicators such as consumer confidence, real wages and interest rates.

In this wider context, a single director purchase or sale is unlikely to be the most informative data point for any given investment decision. Trading updates, annual results and broker upgrades or downgrades usually carry more weight, because they reflect operational data and forward-looking estimates. However, director dealings have one specific advantage: they reflect the actions of insiders who are, by definition, in the best position to understand the company's near-term trajectory. That is why investors may watch director purchases and sales alongside other signals, even when they do not, on their own, indicate future share price performance.

What to watch next

For CVS Group investors, the next set of meaningful disclosures will likely include trading updates from the UK and Australian businesses, any communications relating to the Competition and Markets Authority market investigation into UK vet services, and broader peer-group commentary on clinical labour costs. Investors may also watch for further PDMR dealings, particularly any from board members responsible for capital allocation and strategy. CVSG shares should be considered in the context of these inputs rather than any single director transaction.

Five things investors often overlook about director dealings

First, size matters but is not everything. A small absolute purchase by a senior insider can carry more interpretive weight than a much larger trade by a junior PDMR, particularly when it occurs at a fresh share price low or high. Investors who focus solely on cash values can miss this nuance.

Second, the stated reason for a transaction can transform its meaning. A director sale to fund tax on share option exercises is qualitatively different from a discretionary disposal at the same size and price. The issuer's RNS announcement is the authoritative source for the stated reason and should always be consulted directly.

Third, persons closely associated with PDMRs are subject to the same disclosure regime. Dealings by spouses, dependent children and certain associated legal entities are also disclosed. Aggregator headlines sometimes simplify the attribution, so investors who want full clarity should read the underlying RNS.

Fourth, the share price reaction on the day of a disclosure is often noisy. Intraday moves of less than one percent are unlikely to reflect the dealing itself in any meaningful way. Longer-term share price effects, if any, are typically driven by fundamentals.

Fifth, director dealings are one input among many. They are best read alongside trading updates, broker forecasts, Balance Sheet data, valuation metrics and macroeconomic context. The dealing may draw attention, but it should be assessed alongside fundamentals.